Screening breast MRIs should be considered for women with a personal history of breast cancer.
Women who have had breast cancer are at risk for subsequent breast cancers and should be screened by MRI, according to a study published in the American Journal of Roentgenology.
Researchers from the United States and Japan undertook a retrospective review of screening breast MRIs to assess the importance of a personal history of breast cancer as a risk factor for patients who were referred for screening breast MRI.
The study involved reviewing MR images of 702 patients that were performed from 2004 to 2012. A total of 465 patients underwent annual MRI and 237 had one every six months as part of a research protocol.
The researchers found that of the patients screened, 208 had a personal history of breast cancer and 345 had a family history of breast cancer as the sole risk factor. Ninety-seven patients had both risk factors. The absolute risk for detection of breast cancer at screening MRI was 2.8 percent among patients with a personal history of cancer, and 2.0 percent for patients with a strong family history of cancer.
“The relative risk for detection of breast cancer given a personal history was 1.42 compared with family history,” the authors wrote. “The relative risk when both risk factors were present compared with having only a family history was 3.04.”
The researchers concluded that a personal history of breast cancer was an important risk factor for the development of subsequent breast cancer and should be reason for patients in this group to undergo breast MRI screening.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.